Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Users Online: 810 | Home Print this page Email this page Small font size Default font size Increase font size


 
 Table of Contents  
ORAL PRESENTATION
Year : 2013  |  Volume : 32  |  Issue : 6  |  Page : 36

OA03.13. Clinical evaluation of Amrutadhya Guggulu & Lekhana Basti in Medodushti with special reference to Dyslipidaemia


NIA, Jaipur, India

Date of Web Publication4-Jan-2014

Correspondence Address:
F Ashwini Vinayak
NIA, Jaipur
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0257-7941.123851

Rights and Permissions
  Abstract 

Purpose:
Cardiovascular diseases (CVD) are the major cause of morbidity and mortality in our society with Dyslipidaemia contributing significantly to atherosclerosis. All components of Dyslipidaemia get the most attention because of the link between plasma lipids & CVD, as it is major risk factor for fatal diseases such as Coronary Artery Disease (CAD). As described in Ayurveda, Medodushtijanya Sign & Symptoms shows strikingly resemblance with Dyslipidaemia explained in modern text. Thus while treating the Medodushti, selection of Dravya should have criteria that help to Lekhana of excessive MedaKapha without Vayuprakopa & normalising the Agni both at the level of Jatharagni & Dhatwagni. Thus to assess the efficacy of Lekhana Basti & Amrutadhya Guggulu, present study was planned .
Method:
30 clinically diagnosed & investigated individuals of Dyslipidaemia. Patients were selected from OPD & IPD of Arogyashala, NIA, Jaipur. Patients were administered Amrutadhya Guggulu in dose of 3g/day in three divided doses with 15 Lekhana Basti.
Result:
The results were highly significant in both Subjective as well as Objective parameters.
Conclusion:
Dyslipidaemia is very prevalent in today's society & the risk factor for cardiovascular disorders mostly seen associated with diabetes mellitus & Hypertension.Thus, it can be concluded that from the present clinical trial both the Amrutadhya Guggulu & Lekhana Basti are highly effective in management of the Dyslipidaemia. This study gave very effective, safe, & easily manageable management of Dyslipidaemia in cheaper rate.


How to cite this article:
Vinayak F A, Manohar I N. OA03.13. Clinical evaluation of Amrutadhya Guggulu & Lekhana Basti in Medodushti with special reference to Dyslipidaemia. Ancient Sci Life 2013;32, Suppl S1:36

How to cite this URL:
Vinayak F A, Manohar I N. OA03.13. Clinical evaluation of Amrutadhya Guggulu & Lekhana Basti in Medodushti with special reference to Dyslipidaemia. Ancient Sci Life [serial online] 2013 [cited 2019 Jul 16];32, Suppl S1:36. Available from: http://www.ancientscienceoflife.org/text.asp?2013/32/6/36/123851

From the proceedings of Insight Ayurveda 2013, Coimbatore. 24th and 25th May 2013






 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract

 Article Access Statistics
    Viewed987    
    Printed23    
    Emailed0    
    PDF Downloaded54    
    Comments [Add]    

Recommend this journal